Publication | Closed Access
A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease
72
Citations
25
References
2014
Year
Lithium was safe and well tolerated, but it had no effect on progression when measured using the NESSCA in patients with MJD/SCA3. This slowdown in secondary outcomes deserves further clarification.
| Year | Citations | |
|---|---|---|
Page 1
Page 1